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Abstract
Background: The main objective of this study was to assess and compare patient satisfaction with
Neural Therapy (NT) and conventional medicine (COM) in primary care for musculoskeletal
diseases.
Methods: A cross-sectional study in primary care for musculoskeletal disorders covering 77
conventional primary care providers and 18 physicians certified in NT with 241 and 164 patients
respectively. Patients and physicians documented consultations and patients completed
questionnaires at a one-month follow-up. Physicians documented duration and severity of
symptoms, diagnosis, and procedures. The main outcomes in the evaluation of patients were:
fulfillment of expectations, perceived treatment effects, and patient satisfaction.
Results: The most frequent diagnoses belonged to the group of dorsopathies (39% in COM, 46%
in NT). We found significant differences between NT and COM with regard to patient evaluations.
NT patients documented better fulfilment of treatment expectations and higher overall treatment
satisfaction. More patients in NT reported positive side effects and less frequent negative effects
than patients in COM. Also, significant differences between NT and COM patients were seen in
the quality of the patient-physician interaction (relation and communication, medical care,
information and support, continuity and cooperation, facilities availability, and accessibility), where
NT patients showed higher satisfaction. Differences were also found with regard to the physicians'
management of disease, with fewer work incapacity attestations issued and longer consultation
times in NT.
Conclusion:  Our findings show a significantly higher treatment and care-related patient
satisfaction with primary care for musculoskeletal diseases provided by physicians practising Neural
Therapy.
Background
Musculoskeletal diseases represent a major health prob-
lem throughout the world. No other class of disorders
affects more people, leads to a higher prevalence of disa-
bility, or places a higher financial burden on health sys-
tems [1]. In Switzerland, diseases of the musculoskeletal
system and connective tissue account for more than 20
percent of the recorded main diagnoses [2], and as popu-
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lations age, the prevalence of musculoskeletal diseases is
expected to rise rapidly [1,3]. For various reasons, patients
with musculoskeletal disorders are increasingly choosing
complementary medicine in the search for cures to their
problems. The Swiss Federal Department of Home Affairs
therefore decided in 1998 to add five methods of comple-
mentary medicine, including Neural Therapy (NT), to the
benefit catalogue of basic health insurance for a trial
period of five years. Reimbursements for expenditures in
alternative medicine were covered by basic health insur-
ance only when these methods were provided by physi-
cians with appropriate Complementary and Alternative
Medicine (CAM) training approved by the Swiss Medical
Association. A nationwide evaluation of several CAM pro-
cedures including anthroposophical medicine, homeopa-
thy, traditional Chinese medicine, phytotherapy, and NT
was performed to decide about the inclusion of CAM pro-
cedures in compulsory health plans beyond the trial
period. The project was funded by the Swiss Federal Office
of Public Health and a project description and the respec-
tive results were published in a final report in 2005 [4].
The goal of the current study was to use patient satisfac-
tion as a measure of the effectiveness of NT in ambulatory
care for musculoskeletal diseases as part of the larger
project evaluating CAM procedures. The specific research
question was: What are the differences between NT and
conventional medicine in terms of patient satisfaction
and the patient's evaluation of the quality of the patient-
physician relationship?
Neural Therapy, according to Huneke, is a treatment that
uses precise injections of local anaesthetics for diagnosis
and therapy [5,6]. in which pathological stresses (e.g., a
vicious circle in pain) are interrupted [7]. This treatment
uses the auto-regulatory mechanism of the autonomic
nervous system [5-7] mainly on two levels: in a segmental
reflectory process and in the so-called interference field,
which can cause or maintain pathological processes
beyond any segmental order [5,6]. This implies that NT
can be divided into a local therapy (e.g., infiltration of
trigger points) and a segmental therapy (e.g., therapy of
the Head zones, as well as sympathetic ganglia, nerve
roots, and peripheral nerves) on the one hand and into an
interference field therapy on the other hand. Impulses of
the interference field may influence every system of the
organism beyond that of the segmental order [5,6,8-11].
The mechanism of the effects of NT is derived from the
pathophysiology of pain and from neurophysiological
experiments [7,12-17]. Acute and chronic pain and func-
tional abnormalities, all common findings in patients
with musculoskeletal disorders, are the main indications
for Neural Therapy [5,6].
Within the field of complementary medicine, a consider-
able amount of research has been done that includes
assessments of patient satisfaction [18,19], although little
has been done specifically for NT and musculoskeletal
disorders. We defined patient satisfaction with the follow-
ing items: patient-rated symptom relief, fulfillment of
treatment expectations, overall treatment satisfaction, fre-
quencies of adverse side effects, and a broad range of
aspects of the quality of the patient-physician interaction
covered in the EUROPEP questionnaire [20].
Methods
We examined data related to musculoskeletal diseases as
part of a cross-sectional study conducted between 2002
and 2004. In order to provide a picture of routine care, the
study was designed to be purely observational, without
interference into the treatment choices of patients or the
diagnostic/therapeutic procedures of physicians.
Physicians and patients
A description of sampling procedures used in this study
and of how it is embedded in the main project is given in
Figure 1. The project consisted of two practice studies. Pri-
mary care physicians, including both conventional physi-
cians and those certified by the Swiss Medical Association
for NT (SANTH), were invited to participate in the initial
study (practice study 1) to evaluate differences in the
structure of care. Data regarding professional qualification
and certification were also obtained in this phase. The sec-
ond study (Practice study 2), was aimed at the processes
and outcomes of care, and participating physicians were
invited to recruit patients [4] (Figure 1). The eligibility cri-
teria for all participating physicians were training and a
license in conventional medicine and medical activity in
primary care for at least two days per week. A membership
list of the SANTH was obtained, and all 41 members with
an additional qualification in NT recognized by the Swiss
Medical Association (FMH) were asked to participate.
These physicians were defined in the study as NT physi-
cians. A random sample taken from the complete list of all
Swiss primary care providers, not listed by any medical
society for complementary and alternative medicine, was
also asked to participate in the project. These physicians
were defined as conventional medicine (COM) physi-
cians. The final sample included 18 practitioners who
were certificated in NT and 77 COM practitioners.
Physicians and their staff were instructed to sample con-
secutive patients consulting their practices on four given
days during a 12 month period in 2002/03. The sampling
days for the individual practices were defined by the study
coordination and were equally distributed across seasons
and week days. Patients were sampled irrespective of the
type of appointment they had with their physicians.
Patients were informed about the study by leaflets and
prior to a consultation were asked to fill out forms aimed
at evaluating demographics, health status, and the fre-BMC Complementary and Alternative Medicine 2008, 8:33 http://www.biomedcentral.com/1472-6882/8/33
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Flowchart of sampling procedures Figure 1
Flowchart of sampling procedures.
Practice study 1 (PS 1) 
(overall project)
724   Returned questionnaires 
652   Physicians fulfilling inclusion 
criteria of PS 1 
30 NT 
certified
physicians
317 physicians 
certified in other 
CAM disciplines 
169 physicians not 
CAM certified 
providing CAM+COM 
191 physicians 
providing COM 
only
19 NT 
certified
physicians
171 physicians 
certified in other 
CAM disciplines 
84 physicians 
providing COM 
only
311   physicians selected from PS1 
18 NT 
certified
physicians
77 physicians 
providing COM 
only
Practice study 2 (PS 2) 
(overall project)
Inclusion criteria for PS 2 
- Completed PS1 questionnaire  
- Completed patient  
   questionnaires 
Inclusion criteria for patient satisfaction 
study in Neural Therapy 
- Certification in NT or exclusively providing 
COM
- Completed PS1 questionnaire  
- Completed patient questionnaires of patients 
Inclusion criteria for PS 1 
- Activity in primary care practice 
min 2 days per week 
- Complete PS1 questionnaire  
2266   Physicians selected for the 
projectBMC Complementary and Alternative Medicine 2008, 8:33 http://www.biomedcentral.com/1472-6882/8/33
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quency and reasons for their health care utilization. Phy-
sicians documented the same consultations with reference
to symptoms, diagnoses, duration of problems, comor-
bidities, and diagnostic and therapeutic procedures. The
study design ensured that physicians remained unaware
of the patient answers.
Outcomes were measured using a questionnaire mailed to
patients three to four weeks after the initially documented
consultation. The specific outcomes assessed included:
symptom relief, fulfilment of treatment expectations, sat-
isfaction with treatment, the presence of adverse and
other side effects, and the perceived causality of symptom
relief. Participating patients were also given the EUROPEP
questionnaire, which was developed by an international
group and translated into and validated in multiple lan-
guages. This questionnaire has 23 questions each with a 5-
point answering scale and covers relation and communi-
cation, medical care, information and support, continuity
and cooperation, and facilities availability and accessibil-
ity. Multiple qualitative and quantitative studies have
shown high item response and shown no problems with
the translations [21], which is particularly important for
Switzerland. All the questionnaires (except the
EUROPEP) used in this project were developed in close
cooperation with an expert group of Swiss primary care
providers specialized in conventional and/or complemen-
tary medicine. Questionnaires were sent to patients in
their mother tongue (German, French, or Italian) and
written informed consent was obtained from all partici-
pants. The study was also cleared by the ethics committee
of the Canton Bern (Switzerland).
Data management and data analysis
Only patients over 16 years of age with musculoskeletal
disorders (M chapter of ICD-10) were included in the
analysis (Figure 1). Data analysis was performed in two
steps. The first step included descriptive analyses using
tables and graphs and the second step involved the appli-
cation of analytical procedures. Target variables were ana-
lyzed with multivariate linear models. Ordinal outcomes
such as the measures of health status, severity and chro-
nicity of disease and all data from the EUROPEP question-
naire were reduced to two-level scales with the most
favourable answer category coded as one and all other
non-missing categories as zero. These data were analyzed
using multivariate logistic regression models. The covari-
ables of the multivariate models were defined a priori and
were selected with the aim of adjusting for demographic
factors and the durations of patient's health problems. All
the analytical procedures accounted for the clustering of
observations at the practice level. Taylor series expansion
procedures were used for 2*2 tables, and mixed effects
models for multivariate procedures [22,23]. These proce-
dures allowed us to account for the variation between
physicians in potentially different levels of treatment
quality as perceived by patients by assuming that these
unobserved physician-specific properties have a random
variation. We considered this approach more appropriate
than treating specific properties of single physicians as
fixed effects. 95% confidence intervals (95% CI) of
means, proportions and odds ratios were calculated
accordingly.
The level of significance was set at p < 0.05 throughout the
study, and the statistical software package SAS 9.1 (SAS
Institute Inc., Cary, NC, USA) was used for all calcula-
tions.
Results
Characteristics of patient population
The participating physicians initially recruited 4093
patients, among whom 786 patients (19.2%) were diag-
nosed with musculoskeletal disorders and 494 were
treated with COM and 292 treated with NT). The propor-
tion of patients with musculoskeletal disorders was 16.1%
in COM and 28.5% in NT. A significant difference
between COM and NT was observed in the frequency of
patients that returned questionnaires (241/494 COM
patients (48.8%) and 164/292 (56.2%) NT patients. We
enrolled these 405 patients in the study and compiled
their complete treatment and outcome information. The
proportion of female patients to the whole was 62% in the
COM group and 77% in the NT. The average patient age
was 55.4 years in the COM group and 53.3 years in the NT
(table 1).
Prior to the consultations, patients were asked to rate their
general health on a five-point scale ranging from excellent
to poor. Answer patterns indicate significant differences in
the unadjusted general health status between the COM
and NT patient groups (table 1). For statistical analysis,
the answer scale was dichotomized into "excellent/very
good/good" and "less well/bad". Gender- and age-
adjusted differences indicated no significant differences in
self-rated general health.
Patients recorded the duration of their main health prob-
lem and were classified as acute (duration < 3 months) or
chronic (≥ 3 months). The proportion of chronic patients
was analyzed using a logistic regression model adjusted
for age and gender. This indicated a significantly higher
proportion of chronic patients in the NT group (70.7%)
than in the COM one (48%).
Patients were further asked to rate the severity of their
major health problem using a three-level scale (minor,
moderate or serious). A multivariate logistic regression
model with patient-reported severity as an outcome
(answer level minor coded as 0, and levels moderate andBMC Complementary and Alternative Medicine 2008, 8:33 http://www.biomedcentral.com/1472-6882/8/33
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serious coded as 1) indicated no difference in the severity
of problems between the NT and COM groups after
adjusting for gender, age and the chronicity of disease.
Prevalence of musculoskeletal disease
The most frequent main diagnoses were categorized into
six disease groups (table 2). In both the COM and the NT
group, the most frequent diagnoses belonged to the group
of dorsopathies (39% in COM, 46% in NT). Table 2
shows the recorded sub-diagnoses in the group of dor-
sopathies. Using this classification, there were no signifi-
cant differences between the frequencies of back problems
in COM and NT patients.
Dorsopathies were followed by soft tissue disorders (30%
in both groups), arthropathies (25% in COM, 19% in
NT), osteopathies and chondropathies, other disorders of
the musculoskeletal system and connective tissue, and
systemic connective tissue disorders. The most frequently
recorded ICD-10M diagnoses for COM were radiculopa-
Table 1: Socio-demography and health status of patient population
COM NT
# % 95% CIa #% 9 5 %  C I a
Patients Number 241 164
Patient age Mean 55.42 53.28
Female Patients Proportion 150 62.24 55.9–68.6 126 76.83 71–82.7
Education Proportion of higher education 20.5 14.9–26.1 24.7 16.4–32.9
General healthb excellent 8 3.45 1.03–5.86 4 2.52 0.00–5.32
very good 33 14.22 10.19–18.26 27 16.98 11.95–22.01
good 126 54.31 47.95–60.67 63 39.62 33.48–45.76
fair 53 22.84 17.75–27.94 59 37.11 27.06–47.15
poor 12 5.17 2.40–7.94 6 3.77 0.00–8.15
Duration of the main health problemb Month (Mean) 47.7 32.5–63 72.9 48.5–97.2
Chronic conditionsb > 3 month 116 48.1 42.1–54.2 116 70.7 62.8–78.7
Severe conditionsb 77 34.4 29.3–39.5 60 37.7 31.3–44.1
a 95% confidence limits
bpatient rated
Table 2: Main Diagnoses
Diseases related to the musculoskeletal system (ICD-10) COM NT
# % 95% CIa #% 9 5 %  C I a
M00–25 Arthropathies 60 24.9 18.7–31.1 30 18.3 10.8–25.8
M30–36 Systemic connective tissue disorders 4 1.66 0.1–3.2 3 1.8 0.2–3.4
M40–54 Dorsopathies 95 39.4 32.5–46.3 76 46.3 35.1–57.6
M60–79 Soft tissue disorders 72 29.9 23.3–36.4 49 29.9 20.2–39.5
M80–94 Osteopathies and chondropathies 5 2.07 0.4–3.8 2 1.2 0.0–3.0
M95–99 Other disorders of the musculoskeletal system and connective tissue 5 2.07 0.4–3.8 4 2.4 0.0–5.4
Back-pain diagnoses (M40–M54) 95 39.4 32.5–46.3 88 53.7 35.1–57.6
M43 Other deforming dorsopathies 4 1.7 1 0.6
M45 Ankylosing spondylitis 1 0.4 0 0
M47 Spondylosis 3 1.2 3 1.8
M48 Other spondylopathies 3 1.2 1 0.6
M51 Other intervertebral disc disorders 6 2.5 4 2.4
M53 Other dorsopathies, not elsewhere classified 3 1.2 15 9.2
M54 Dorsalgia 75 31.1 52 31.7
Comorbid conditions
None 101 41.9 34.3–49.6 51 31.1 20.8–41.4
1 61 25.3 19.8–30.8 58 35.4 29.4–41.3
> 1 79 32.8 25–40.6 55 33.5 21.7–45.4
a 95% confidence limitsBMC Complementary and Alternative Medicine 2008, 8:33 http://www.biomedcentral.com/1472-6882/8/33
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thy, low back pain, and cervicalgia. The most frequent
diagnoses for NT were cervicalgia, myalgia (not elsewhere
classified), and cervicobrachial syndrome.
The concomitance of comorbidities allows for a measure
of disease severity. The distribution of the frequency of
comorbidities is shown in table 2. There was no statisti-
cally significant difference between COM and NT.
Patient attitudes and expectations (table 3)
No differences were found between the COM and NT
groups with respect to the patient's expectations for heal-
ing, symptom relief, agreeable method, side effects and
lower cost.
Management of disease (physicians)
No significant differences between groups were observed
for diagnostic and therapeutic referrals to other physicians
and specialists (10.5% in NT, 13.3% in COM). However,
NT physicians had significantly longer consultations than
their COM peers (19.1 minutes in NT, 17.1 minutes in
COM). Our results also show that NT physicians issued
work incapacity attestations for a population of patients
under 65 less often than COM physicians (3.2% in NT,
17.0% in COM).
Patient evaluations (table 4)
Unadjusted results for symptom relief indicated generally
poorer outcomes for NT patients. However, after adjusting
the analysis for gender, age, and the chronicity of disease,
no significant differences were observed for the propor-
tion of patients with a complete resolution of symptoms.
The fulfillment of treatment expectations was rated using
a four-point scale ranging from complete fulfillment to
not at all. Unadjusted comparison of frequency indicated
no significant difference in the fulfillment of expectations
between the groups. However, after analysis with an age-,
gender-, and chronicity-adjusted logistic regression model
of complete fulfillment of expectations, a significantly
better outcome was observed for NT patients.
The unadjusted general treatment satisfaction, rated from
very satisfied to not satisfied at all showed significant dif-
ferences between groups. The age-, gender-, and chronic-
ity-adjusted frequencies of very satisfied answers indicated
significantly higher treatment satisfaction in NT patients.
The majority of COM (87%) and NT (89.4%) patients did
not report treatment-related adverse side effects, and the
difference between groups was not significant. Differences
between groups were seen in the severity of side effects
with a tendency for less severe effects in the NT group
(table 4). NT patients also reported additional positive
effects not directly related to their main health problems,
and observed other additional effects with less frequency.
The causality of symptom relief was analysed by asking
patients to what degree they considered symptom amelio-
ration to be the consequence of a specific treatment. There
were significant differences between the groups with NT
patients more often confident that the amelioration of
their symptoms was as a result of the treatment performed
(table 4).
EUROPEP questionnaire (table 5)
For all EUROPEP questions, with the exception of 10, 19,
and 20, NT patients indicated higher satisfaction and the
differences between the groups for questions 2, 3, 6, 7, 8,
9, 12, 13, 15, 17, and 18 were statistically significant.
Discussion
This study was part of a nationwide evaluation of comple-
mentary medicine in Swiss primary care. Its specific objec-
tive was to assess patient satisfaction for the treatment of
musculoskeletal diseases with Neural Therapy compared
to conventional medicine. Although NT accounts for only
a small fraction of Swiss primary care; in 2002 only 1.2%
of all primary care providers (69 practitioners) had the
respective certification, our results may nevertheless pro-
vide some important information for the treatment of
musculoskeletal diseases, and, in particular, spine prob-
lems. The considerable difference we observed between
COM and NT in the proportion of patients with muscu-
loskeletal problems indicates a certain attraction to NT
that other research confirms [5,6,24-28]. Our study may
be criticized for data that are mainly based on perceived
health status and self-reported, subjective assessments of
Table 3: Patient expectations
COM NT
# % 95% CIa #% 9 5 %  C I a
Expectations Healing 112 46.5 40.1–53.8 82 50.0 41.3–58.7.0
Alleviation 128 53.1 47.5–58.8 86 52.4 42.4–62.5
Agreeable method 5 2.1 0.3–3.8 2 1.2 0.0–3.5
Less adverse side effects 22 9.1 5.1–13.1 30 18.3 11.2–25.4
Lower costs 2 0.8 0.0–2.0 4 2.4 0.3–4.5
a 95% confidence limitsBMC Complementary and Alternative Medicine 2008, 8:33 http://www.biomedcentral.com/1472-6882/8/33
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patients, but such evaluations have proven to be valid
measures of health in general populations [29,30]. A
related, important finding is that NT patients considered
their general health and the severity of major health prob-
lems to be the same as those of COM patients, whereas
other findings on complementary medicine report poorer
general health and more severe disease conditions for NT
patients compared to COM patients [8]. However, in
accordance with the literature NT patients more often
reported chronic health problems than COM patients [31-
34].
The management of musculoskeletal disorders appeared
to be different in NT and conventional primary care. NT
physicians had longer consultations, but they issued work
incapacity attestations less often than their conventional
colleagues. These have consequences on the direct and
indirect costs of treatment. Longer consultations, which
are likely the result of the invasive character of NT,
increase the direct costs, but fewer work incapacity attesta-
tions may result in lower indirect costs. Musculoskeletal
disorders, especially those related to back-pain, cause an
enormous economic burden on health care systems [1],
and back-pain itself appears to be a major factor in lost
work productivity [35]. Our data therefore provide some
empirical evidence that increased use of NT in primary
care may result in lower health care expenditures in Swiss
ambulatory care.
Our interpretation of patient satisfaction data discrimi-
nated between treatment-related outcomes (symptom
relief, fulfillment of treatment expectations, adverse side
effects, and other effects) and care-related outcomes
(overall satisfaction with treatment, and the EUROPEP
questionnaire) is that there are equal or better outcomes
when measured by treatment-related items, and also con-
sistently better outcomes for all care-related items. How-
ever, some contradictions were seen in the patients'
evaluations of symptom relief. No difference was found
between the groups when patients were asked about
symptom relief, but significantly more NT patients
reported quick relief of symptoms (EUROPEP-question
7).
We did not find a difference between NT and COM with
respect to patient based reports of adverse side effects. The
observations that patients in NT have more often reported
positive effects and COM patients have more often per-
ceived negative effects may reinforce the idea that patient
expectations and outcomes are linked [36,37]. However,
it has to be acknowledged that the reports of adverse side
effects were based on evaluations by patients and not on
more objective clinical criteria.
It can be argued that the consistently higher satisfaction
expressed in the EUROPEP questionnaire by NT patients
is likely the result of longer consultation times in NT [38],
Table 4: Patient evaluations
COM NT
#%9 5 %  C I a # % 95% CIa
Symptom relief Complete resolution* 30 12.9 7.8–18.1 12 7.4 3.1–11.7
Considerably weaker 68 29.3 23.5–35.2 64 39.5 32.9–46.1
Somehow weaker 63 27.2 20.8–33.5 47 29.0 22.0–36.0
Unchanged 61 26.3 20.7–31.9 34 21 16.2–25.8
Very intense 9 3.9 1.4–6.4 4 2.5 0.2–4.7
Unsupportable 1 0.4 0–1.3 1 0.6 0–1.8
Fulfillment of treatment expectations* Proportion of "complete fulfilled" 33 15 9.6–20.5 40 24.8 18.5–31.2
Overall Satisfaction* Proportion of "very satisfied" 66 29.5 22.7–36.2 66 41.3 35.9–46.6
Adverse side effects Yes 29 12.9 8.4–17.5 17 10.6 8.2–12.9
Severity of side effects weak 4 13.8b 1.6–26.0 7 41.2 13.1–69.2
moderate 18 62.1 45.2–78.9 5 29.4 6.9–52.0
strong 7 24.1 7.6–40.7 5 29.4 7.7–51,2
Other effects* Positive 38 17.7 13.1–22.3 59 37.6 29.1–46.1
Negative 16 7.4 3.8–11.1 9 5.7 2.5–9.0
No effect 161 74.9 70.3–79.5 89 56.7 47.0–66.4
Perceived causality of symptom relief* Very sure 59 29.7 22.2–37.1 62 44.3 36.0–52.6
Sure 77 38.7 31.0–46.4 55 39.3 29.9–48.7
Not sure 39 19.6 13.7–25.5 12 8.6 4.1–13.1
Don't know 24 12.1 7.0–17.1 11 7.9 3.1–12.6
*significant difference (p < 0.05) in the proportion of the most favorable answer option between NT and COM in a multivariate logistic model (age, 
gender and chronicity controlled)
a 95% confidence limits
b percentage of patients with adverse side effects within groupBMC Complementary and Alternative Medicine 2008, 8:33 http://www.biomedcentral.com/1472-6882/8/33
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although there is some debate about which aspects of the
physicians behaviour affect patient-based evaluations in
primary care [39]. However, some particular characteris-
tics of NT need to be considered in this context. The first
part of a consultation in NT, consisting of anamnesis and
examination, is comparable to conventional medicine
and requires the same amount of time. The second part of
a NT consultation usually includes an injection that actu-
ally harms the patient. Longer consultations in NT are
therefore not related to extended communication time
between patients and physicians but are mostly due to the
duration of a specific therapeutic procedure.
Limitations of the study
Several limitations of the study can be acknowledged.
With reference to external validity, the extent to which the
study results can be generalized is limited by the small
sample size of patients with musculoskeletal diseases
(241-COM, 164-NT) and their physicians (77-COM, 18-
NT). It is impossible to asses the validity of this sample
size as the overall distribution of patients with muscu-
loskeletal problems in Swiss primary care is unknown.
However, other research within the larger project showed
that the original samples of physicians and patients, irre-
spective of diagnosis related inclusion criteria, were rea-
sonably representative of their respective base
populations [2,40].
Potential sources of bias in this study include the fact that
satisfied and dissatisfied patients have different compli-
ance in completing questionnaires. It is therefore very
Table 5: Patient satisfaction (EUROPEP)
Questions/items COM NT
%9 5 %  C I a % 95% CIa
Relation and communication
1. Making you feel you had time during consultation? 60.6 53.9–67.3 70.3 53.3–87
2. Interest in your personal situation?* 58.6 52.1–65 72 60–83.9
3. Making it easy for you to tell him or her about your problem?* 61.1 53.2–69 71.9 59–84.8
4. Involving you in decisions about your medical care? 55.7 48.1–63.4 64.7 54.2–75.1
5. Listening to you? 65.8 59.1–72.5 73.7 61.1–86.3
6. Keeping your records and data confidential?* 69.5 62.4–76.7 83.1 74.6–91.6
Medical care
7. Quick relief of your symptoms?* 16.1 10.3–22 26.6 20.3–32.9
8. Helping you to feel well so that you can perform your normal daily activities?* 27 20.2–33.8 40.7 32.7–48.8
9. Thoroughness?* 50.5 43.1–57.8 68.4 59.6–77.1
10. Physical examination of you? 47.1 40.7–53.4 55.7 38.8–72.6
11. Offering you services for preventing diseases (screening, health checks, immunizations)? 43 34.2–51.9 54.3 41.9–66.7
Information and support
12. Explaining the purpose of tests and treatments?* 57.1 50.2–64.1 72.7 64.9–80.5
13. Telling you what you wanted to know about your symptoms and/or illness?* 55.4 48.1–62.7 71.2 60.4–81.9
14. Helping you deal with emotional problems related to your health status? 47.8 40.3–55.2 57.9 44.6–71.2
15. Helping you understand the importance of following his or her advice?* 44.1 37.2–51.1 61.7 51.4–71.9
Continuity and cooperation
16. Knowing what s/he had done or told you during earlier contacts? 53.2 45.2–61.2 63.5 50.3–76.7
17. Preparing you for what to expect from specialist or hospital care?* 53.4 44.9–61.8 76.8 64.9–88.6
Facilities availability and accessibility
18. The helpfulness of the staff (other than the doctor)?* 64.3 57.9–70.7 74.8 65.8–83.9
19. Getting an appointment to suit you? 1.3 0–2.7 1.2 0.0–3.1
20. Getting through to the practice on telephone? 73.5 65.9–81.1 69.1 56.5–81.8
21. Being able to speak to the general practitioner on the telephone? 54.9 46.4–63.3 58.9 42.3–75.6
22. Waiting time in the waiting room? 36.3 27.8–44.8 42.8 31.4–54.2
23. Providing quick services for urgent health problems? 67.7 59.7–75.6 70.2 61.5–79.0
*significant difference in the proportion of the most favorable answer option (p < 0.05) between NT and COM in a multivariate logistic model (age, 
gender and chronicity controlled)
a 95% confidence limitsBMC Complementary and Alternative Medicine 2008, 8:33 http://www.biomedcentral.com/1472-6882/8/33
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likely that the results are positively biased because satis-
fied patients are more likely to return the questionnaires
[41,42].
The study was based on a cross-sectional design and
patients received a questionnaire 3–4 weeks after a single
consultation, irrespective whether they had other
appointments with a physician within or outside the
study. This implies that the description and comparison
of the satisfaction of the two patient groups may not fully
account for effectiveness of procedures in an ongoing
therapeutic process. It may also be possible that work
incapacity attestations were either pre-existing or issued
by other, non-study physicians.
Other limitations of the study are related to the fact that
outcome measures such as the EUROPEP are not specific
for musculoskeletal disorders and may not be appropriate
for assessing patient satisfaction with NT. The broad range
of outcomes assessed in the survey, which was not origi-
nally intended to specifically evaluate diseases treated by
NT, made it impossible to investigate essential issues as
deeply as would have been possible in a survey designed
specifically to assess patient satisfaction with NT. An eval-
uation of long-term effects and chronic disease, which is
also important, was not in the scope of the overall project.
Another problem of the study relates to the limitations in
diagnosing musculoskeletal diseases in a primary care set-
ting where sophisticated imaging is usually not available.
Such limitations are, however, present in both COM and
NT. Bias as a result of uneven diagnostic certainty across
study groups may therefore not be a concern.
Patient questions other than the EUROPEP questionnaire
were not validated. Limited temporal and financial
resources in the project made a respective psychometric
validation for three different languages prohibitive. How-
ever, literature provides support that patient evaluations
of care give valid estimates of their experiences and respec-
tive satisfaction in a primary care setting [43,44]. It may
also be criticized that outcomes were dichotomized into
the best possible and all other answer options. This
approach is based on a commonly applied concept that
standards of excellence attained by top performers should
be used as benchmarks of quality in the health care sector
[45].
Finally, it can be argued that the analysis of our outcome
data needs adjustment for the problem of multiple tests.
The literature in this field is inconclusive [46] and the
decision whether to view the EUROPEP data as a group or
as individual questions remains arbitrary. This study has
the character of a pilot study and we therefore promote a
more informal use of the hypothesis tests, which implies
that the results are important but the p-values have little
meaning. Consequently, it is possible that our results acci-
dentally mislead the interpretation of individual ques-
tions as significant p-values can occur by chance alone.
However, the EUROPEP results showed consistently bet-
ter outcomes for NT in almost all questions and we con-
sider it unlikely that the overall interpretation of the data
was affected by accidentally significant p-values.
Conclusion
In light of the high prevalence of musculoskeletal disor-
ders, our results that show significantly higher patient sat-
isfaction in NT may have practical importance. Better
patient satisfaction and better fulfillment of expectations
along with an equal patient-perceived efficacy in the treat-
ment of musculoskeletal disorders make NT treatment an
option for primary care or referring physicians. Increased
application of neuraltherapeutics by primary care physi-
cians could therefore be considered reasonable and
increased integration of NT in medical education would
also be justified. However, further research is needed to
establish outcomes that are more evidence based, and to
provide a more in-depth analysis of the cost-effectiveness
of NT.
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